Lautenbach E - Search Results

1

Trends in antimicrobial susceptibility patterns among inpatient enterococcal isolates (1990 to 1999): implications for therapeutic options.

Lautenbach E, Patel JB, Bilker WB, Fishman NO. Lautenbach E, et al. Infect Control Hosp Epidemiol. 2002 Aug;23(8):416-8. doi: 10.1086/503470. Infect Control Hosp Epidemiol. 2002. PMID: 12186203 No abstract available.

2

The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus.

Lautenbach E, Schuster MG, Bilker WB, Brennan PJ. Lautenbach E, et al. Clin Infect Dis. 1998 Nov;27(5):1259-65. doi: 10.1086/515002. Clin Infect Dis. 1998. PMID: 9827280

3

Control of outbreaks due to organisms producing extended-spectrum beta-lactamases.

Lautenbach E, Fishman NO. Lautenbach E, et al. JAMA. 1999 Mar 24-31;281(12):1080-1. doi: 10.1001/jama.281.12.1080. JAMA. 1999. PMID: 10188649 No abstract available.

4

Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.

Lautenbach E, Bilker WB, Brennan PJ. Lautenbach E, et al. Infect Control Hosp Epidemiol. 1999 May;20(5):318-23. doi: 10.1086/501624. Infect Control Hosp Epidemiol. 1999. PMID: 10349947

5

Wagging the dog: antibiotic use and the emergence of resistance.

Lautenbach E, Fishman NO. Lautenbach E, et al. J Gen Intern Med. 1999 Oct;14(10):643-5. doi: 10.1046/j.1525-1497.1999.t01-1-07029.x. J Gen Intern Med. 1999. PMID: 10571711 Free PMC article. No abstract available.

6

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Lautenbach E, et al. Clin Infect Dis. 2001 Apr 15;32(8):1162-71. doi: 10.1086/319757. Epub 2001 Mar 26. Clin Infect Dis. 2001. PMID: 11283805

7

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Lautenbach E, et al. Clin Infect Dis. 2001 Oct 15;33(8):1288-94. doi: 10.1086/322667. Epub 2001 Sep 14. Clin Infect Dis. 2001. PMID: 11565067

8

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.

Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E. Bisson G, et al. Among authors: lautenbach e. Infect Control Hosp Epidemiol. 2002 May;23(5):254-60. doi: 10.1086/502045. Infect Control Hosp Epidemiol. 2002. PMID: 12026150

9

Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections.

Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL. Lautenbach E, et al. Arch Intern Med. 2002 Nov 25;162(21):2469-77. doi: 10.1001/archinte.162.21.2469. Arch Intern Med. 2002. PMID: 12437407

10

Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins.

Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Lautenbach E, et al. Clin Infect Dis. 2003 Feb 15;36(4):440-6. doi: 10.1086/346153. Epub 2003 Jan 24. Clin Infect Dis. 2003. PMID: 12567301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters